These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 2147930)

  • 1. [Acute bacterial salpingitis. The importance of residual inflammation. A comparative study with celioscopic control of 2 antibiotic protocols: sulbactam-ampicillin versus cefoxitin].
    Le Bouedec G; Pouly JL; Mage G; Canis M; Wattiez A; Abbas Muhktar B; Bruhat MA
    J Gynecol Obstet Biol Reprod (Paris); 1990; 19(6):765-72. PubMed ID: 2147930
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of acute salpingitis with sulbactam/ampicillin.
    Bruhat MA; LeBouedec G; Pouly JL; Mage G; Canis M
    Suppl Int J Gynecol Obstet; 1989; 2():41-6; discussion 47-8. PubMed ID: 2529873
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of acute salpingitis with sulbactam/ampicillin. Comparison with cefoxitin.
    Bruhat MA; Pouly JL; Le Boedec G; Mage G
    Drugs; 1986; 31 Suppl 2():7-10. PubMed ID: 3013571
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single-agent therapy for acute pelvic inflammatory disease: sulbactam/ampicillin versus cefoxitin.
    Hemsell DL; Bawdon RE; Hemsell PG; Nobles BJ; Heard MC
    J Int Med Res; 1990; 18 Suppl 4():85D-89D. PubMed ID: 2282973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ampicillin/sulbactam and cefoxitin in the treatment of cutaneous and other soft-tissue abscesses in patients with or without histories of injection drug abuse.
    Talan DA; Summanen PH; Finegold SM
    Clin Infect Dis; 2000 Aug; 31(2):464-71. PubMed ID: 10987706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ampicillin/sulbactam versus cefazolin or cefoxitin in the treatment of skin and skin-structure infections of bacterial etiology.
    Chan JC
    Adv Ther; 1995; 12(2):139-46. PubMed ID: 10150324
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sulbactam/ampicillin versus cefoxitin in the treatment of obstetric and gynaecological infections.
    Senft HH; Stiglmayer R; Eibach HW; Koerner H
    Drugs; 1986; 31 Suppl 2():18-21. PubMed ID: 3013568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ampicillin-sulbactam versus cefoxitin for prophylaxis in high-risk patients undergoing abdominal surgery.
    Paladino JA; Rainstein MA; Serrianne DJ; Przylucki JE; Welage LS; Collura ML; Schentag JJ
    Pharmacotherapy; 1994; 14(6):734-9. PubMed ID: 7885978
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conversion of treatment from cefoxitin to ampicillin/sulbactam: experience in a university teaching hospital.
    Kitrenos JG; Rotella DL; Nakasato S
    Adv Ther; 1995; 12(1):30-43. PubMed ID: 10150321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of ampicillin/sulbactam and cefoxitin in the treatment of bacterial skin and skin-structure infections.
    Weigelt JA
    Adv Ther; 1994; 11(4):183-91. PubMed ID: 10150262
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Acute salpingitis. Celioscopy before and after treatment: 110 cases].
    Le Bouëdec G; Pouly JL; Canis M; Wattiez A; Abbas B; Mage G; Bruhat MA
    J Gynecol Obstet Biol Reprod (Paris); 1991; 20(5):680-4. PubMed ID: 1835469
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacoeconomic analysis of ampicillin-sulbactam versus cefoxitin in the treatment of intraabdominal infections.
    Messick CR; Mamdani M; McNicholl IR; Danziger LH; Rodvold KA; Condon RE; Walker AP; Edmiston CE
    Pharmacotherapy; 1998; 18(1):175-83. PubMed ID: 9469691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The role of anti-inflammatory agents in the treatment of acute salpingitis. A randomized study of 40 patients with celioscopic control].
    Bassil S; Le Bouedec G; Mage G; Pouly JL; Canis M; Wattiez A; Chapron C; Bruhat MA
    J Gynecol Obstet Biol Reprod (Paris); 1991; 20(8):1063-7. PubMed ID: 1839799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic interchange of ampicillin-sulbactam for cefoxitin.
    Lawrenz CA; Cole P; Theodorou A; Cook RL; Bermann L
    Am J Hosp Pharm; 1991 Oct; 48(10):2150-4. PubMed ID: 1781470
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of a beta-lactamase inhibitor combination for serious intraabdominal infections.
    Walker AP; Nichols RL; Wilson RF; Bivens BA; Trunkey DD; Edmiston CE; Smith JW; Condon RE
    Ann Surg; 1993 Feb; 217(2):115-21. PubMed ID: 8439209
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical efficacy of sulbactam/ampicillin in the treatment of moderately severe bacterial infections.
    Fong KY; Howe HS; Boey ML; Feng PH
    Singapore Med J; 1989 Apr; 30(2):170-2. PubMed ID: 2609176
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of acute pelvic inflammatory disease in the ambulatory setting: trial of cefoxitin and doxycycline versus ampicillin-sulbactam.
    Kosseim M; Ronald A; Plummer FA; D'Costa L; Brunham RC
    Antimicrob Agents Chemother; 1991 Aug; 35(8):1651-6. PubMed ID: 1929337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sulbactam/ampicillin combination in the treatment of acute and chronic lower respiratory infections.
    Bisetti A; Grassi L; Scacciacillani E; Putti P
    J Int Med Res; 1991; 19 Suppl 1():36A-43A. PubMed ID: 2060692
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Sulbactam-ampicillin in surgery. Our experience].
    Germiniani R; Casiraghi S; Pace M; Caspani P; Trabucchi E
    Minerva Chir; 1992 Oct; 47(20):1627-9. PubMed ID: 1480290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Abdominal surgical wound infection is lowered with improved perioperative enterococcus and bacteroides therapy.
    Weigelt JA; Easley SM; Thal ER; Palmer LD; Newman VS
    J Trauma; 1993 Apr; 34(4):579-84; discussion 584-5. PubMed ID: 8487344
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.